Friday 04 Apr, 2025 02:20 PM
Site map | Locate Us | Login
   Emcure Pharma's European arm acquires Manx Healthcare for '19.7 million    Metal stocks edge lower    Reliance Industries Ltd slips for fifth straight session    J&K Bank records 11% YoY growth in gross advances in Q4 FY25    IEX records 18% YoY rise in traded electricity volume in Q4 FY25    Vedanta records aluminium production of 6.03 lakh tonnes in Q4    Premier Energies incorporates wholly owned subsidiary    Marico Ltd gains for third straight session    Adani Wilmar reports 7% volume growth in Q4 FY25    Pharma stocks tumble as Trump hints at unprecedented tariffs    VIP Clothing Ltd leads gainers in 'B' group    Union Bank of India slides after missing loan growth and deposit guidance    Mazagon Dock slides as OFS begins; promoter to sell 4.83% stake    Kaveri Seed Company Ltd leads gainers in 'A' group    Bharat Global Developers hits the floor after CEO resignation 
Saravan Stocks
       
Company Background
Shukra Pharmaceuticals Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
524632 INE551C01044 1.2397304 N.A 0.12 901.16 108.32 0.19 1
Incorporation Year 1993  
Registered Office 3 rd Floor Dev House,Opp WIAA Office Judges Bungalo,
Ahmedabad,
Gujarat-380054
Telephone 91-079-66522247/27498515  
Fax NA  
Chairman Dakshesh Shah  
Managing Director Dakshesh Shah  
Company Secretary Arpita Kabraa  
Auditor MAAK & Associates  
Face Value 1  
Market Lot 1  
Listing BSE  
Registrar Purva Sharegistry (I) Pvt Ltd
9 ShivShakti Indl Es,J R Boricha Marg,Lower Parel,Mumbai - 400 011
 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 39972688
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd